GSK launches Polident in India
Polident denture fixative cream creates a seal between denture and gum tissues - keeping out food particles and providing a strong, all day hold for dentures.
New Delhi: GSK Consumer Healthcare on Wednesday said it has forayed into specialised denture care category in India with the introduction of Polident brand.
With the launch of Polident, which is the global market leader in the denture care, the company has reinforced its presence in the overall oral health category in India, GSK Consumer Healthcare said in a statement.
It also enables the company to make a meaningful difference to lives of millions of denture wearers in India – in line with its purpose of introducing products that help people do more, feel better and live longer, it added.
"Today, 1 out of every 7 Indian above the age of 45 wears a denture, which means there are millions of denture wearers in our country. Only 5 percent of these denture wearers use specialist denture care products,' GSK Consumer Healthcare Area Marketing Director Oral Health Anurita Chopra said.
GSK consumer healthcare has always endeavored to introduce products keeping needs of consumers in mind, she added.
'We realised the attention required by the category in India and therefore decided to bridge the gap by introducing Polident denture fixative in India. Being a consumer preferred and leading denture care brand globally, we are confident that Polident will be well received in India,' Chopra said.
Polident denture fixative cream creates a seal between denture and gum tissues – keeping out food particles and providing a strong, all day hold for dentures.
The product will be available pan-India across pharmacies and leading e-commerce platforms, the company said.
Read also: GSK to launch final testing of respiratory syncytial virus vaccine
It is available in a pack size of 20 gm with MRP of Rs 315, it added.
Currently, GSK's oral health portfolio consists of Sensodyne range of toothpaste and toothbrush especially designed for people with sensitive teeth.
Read also: GSK, Sanofi to supply 200 million COVID vaccine doses to COVAX facility
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.